Resultats de la cerca - Henk‐Jan Guchelaar

Refinar resultats
  1. 1
    Immunogenicity of Monoclonal Antibodies and the Potential Use of HLA Haplotypes to Predict Vulnerable Patients

    Immunogenicity of Monoclonal Antibodies and the Potential Use of HLA Haplotypes to Predict Vulnerable Patients per Romy Mosch, Henk‐Jan Guchelaar

    Publicat 2022
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  2. 2
    The efficacy and safety of eculizumab in patients and the role of C5 polymorphisms

    The efficacy and safety of eculizumab in patients and the role of C5 polymorphisms per Hendrikus Bernhard Bouwman, Henk‐Jan Guchelaar

    Publicat 2024
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  3. 3
    Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis

    Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis per Judith A.M. Wessels, T. Huizinga, Henk‐Jan Guchelaar

    Publicat 2007
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  4. 4
    Estimated nationwide impact of implementing a preemptive pharmacogenetic panel approach to guide drug prescribing in primary care in The Netherlands

    Estimated nationwide impact of implementing a preemptive pharmacogenetic panel approach to guide drug prescribing in primary care in The Netherlands per Paul CD Bank, Jesse J. Swen, Henk‐Jan Guchelaar

    Publicat 2019
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Diagnostic Test Criteria for HLA Genotyping to Prevent Drug Hypersensitivity Reactions: A Systematic Review of Actionable HLA Recommendations in CPIC and DPWG Guidelines

    Diagnostic Test Criteria for HLA Genotyping to Prevent Drug Hypersensitivity Reactions: A Systematic Review of Actionable HLA Recommendations in CPIC and DPWG Guidelines per Lisanne E. N. Manson, Jesse J. Swen, Henk‐Jan Guchelaar

    Publicat 2020
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  6. 6
    Clinical development of gene- and cell-based therapies: overview of the European landscape

    Clinical development of gene- and cell-based therapies: overview of the European landscape per Sofieke de Wilde, Henk‐Jan Guchelaar, Maarten L. Zandvliet, Pauline Meij

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    Pre-therapeutic UGT1A1 genotyping to reduce the risk of irinotecan-induced severe toxicity: Ready for prime time

    Pre-therapeutic UGT1A1 genotyping to reduce the risk of irinotecan-induced severe toxicity: Ready for prime time per Emma C. Hulshof, Maarten J. Deenen, Henk‐Jan Guchelaar, Hans Gelderblom

    Publicat 2020
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  8. 8
    Phenoconversion of Cytochrome P450 Metabolism: A Systematic Review

    Phenoconversion of Cytochrome P450 Metabolism: A Systematic Review per Sylvia D. Klomp, Martijn L. Manson, Henk‐Jan Guchelaar, Jesse J. Swen

    Publicat 2020
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  9. 9
    Technologies for Pharmacogenomics: A Review

    Technologies for Pharmacogenomics: A Review per Maaike van der Lee, Marjolein Kriek, Henk‐Jan Guchelaar, Jesse J. Swen

    Publicat 2020
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  10. 10
    Applying Next-Generation Sequencing Platforms for Pharmacogenomic Testing in Clinical Practice

    Applying Next-Generation Sequencing Platforms for Pharmacogenomic Testing in Clinical Practice per Alireza Tafazoli, Henk‐Jan Guchelaar, Wojciech Miltyk, Adam Krętowski, Jesse J. Swen

    Publicat 2021
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  11. 11
    3D Printing of Pediatric Medication: The End of Bad Tasting Oral Liquids?—A Scoping Review

    3D Printing of Pediatric Medication: The End of Bad Tasting Oral Liquids?—A Scoping Review per Iris Lafeber, Elisabeth J. Ruijgrok, Henk‐Jan Guchelaar, Kirsten J. M. Schimmel

    Publicat 2022
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    Concordance of Predictive Markers for EGFR Inhibitors in Primary Tumors and Metastases in Colorectal Cancer: A Review

    Concordance of Predictive Markers for EGFR Inhibitors in Primary Tumors and Metastases in Colorectal Cancer: A Review per Jara M. Baas, L. L. Krens, Henk‐Jan Guchelaar, Hans Morreau, Hans Gelderblom

    Publicat 2011
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  13. 13
    Lapatinib for Advanced or Metastatic Breast Cancer

    Lapatinib for Advanced or Metastatic Breast Cancer per Frans L. Opdam, Henk‐Jan Guchelaar, Jos H. Beijnen, Jan H.M. Schellens

    Publicat 2012
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  14. 14
    Medical education in pharmacogenomics—results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation project Ubiquitous Pharmacogenomics (U-PGx)

    Medical education in pharmacogenomics—results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation pr... per Katja S. Just, Michael Steffens, Jesse J. Swen, George P. Patrinos, Henk‐Jan Guchelaar, Julia Stingl

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    The Risk of Cancer in Users of Statins

    The Risk of Cancer in Users of Statins per Matthijs R. Graaf, Annette B. Beiderbeck, Toine C. G. Egberts, Dick J. Richel, Henk‐Jan Guchelaar

    Publicat 2004
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    Individualized Dosing of Fluoropyrimidine‐Based Chemotherapy to Prevent Severe Fluoropyrimidine‐Related Toxicity: What Are the Options?

    Individualized Dosing of Fluoropyrimidine‐Based Chemotherapy to Prevent Severe Fluoropyrimidine‐Related Toxicity: What Are the Options? per Jonathan E. Knikman, Hans Gelderblom, Jos H. Beijnen, Annemieke Cats, Henk‐Jan Guchelaar, Linda M. Henricks

    Publicat 2020
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  17. 17
    Liver and kidney function in patients with Covid‐19 treated with remdesivir

    Liver and kidney function in patients with Covid‐19 treated with remdesivir per Sylvia A. van Laar, Mark de Boer, Kim B. Gombert‐Handoko, Henk‐Jan Guchelaar, J. Zwaveling

    Publicat 2021
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    Estrogens, oral contraceptives and hormonal replacement therapy increase the incidence of cutaneous melanoma: a population-based case–control study

    Estrogens, oral contraceptives and hormonal replacement therapy increase the incidence of cutaneous melanoma: a population-based case–control study per E.R. Koomen, Arjen Joosse, Ron M. C. Herings, M. K. Casparie, Henk‐Jan Guchelaar, Tamar Nijsten

    Publicat 2008
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    Low literacy and written drug information: information-seeking, leaflet evaluation and preferences, and roles for images

    Low literacy and written drug information: information-seeking, leaflet evaluation and preferences, and roles for images per Mara M. van Beusekom, Petronella Grootens‐Wiegers, Mark Bos, Henk‐Jan Guchelaar, Jos M. van den Broek

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    The extent and effects of patient involvement in pictogram design for written drug information: a short systematic review

    The extent and effects of patient involvement in pictogram design for written drug information: a short systematic review per Mara M. van Beusekom, Anne H. Kerkhoven, Mark Bos, Henk‐Jan Guchelaar, Jos M. van den Broek

    Publicat 2018
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:

Eines de cerca: